See more : Yield10 Bioscience, Inc. (YTEN) Income Statement Analysis – Financial Results
Complete financial analysis of Fine Organic Industries Limited (FINEORG.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fine Organic Industries Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- True Data Inc. (4416.T) Income Statement Analysis – Financial Results
- Vector Acquisition Corporation (VACQU) Income Statement Analysis – Financial Results
- Genflow Biosciences plc (GENF.L) Income Statement Analysis – Financial Results
- Beghelli S.p.A. (BE.MI) Income Statement Analysis – Financial Results
- West Wits Mining Limited (WMWWF) Income Statement Analysis – Financial Results
Fine Organic Industries Limited (FINEORG.NS)
About Fine Organic Industries Limited
Fine Organic Industries Limited engages in manufacture, processing, supply, distribution, and import of oleochemical-based additives in India and internationally. It offers food additives, such as emulsifiers, antifungal additives, and other specialty additive blends; plastic additives, including dispersing agents, processing aids, anti-stats, flow improvers, lubricants, slip additives, and antifogging additives for polymers, polymer compounds and masterbatches, foamed products, PVC products, and engineering plastics; cosmetic and pharmaceutical additives; coating additives; and additives for other specialty application in various industries. The company was founded in 1970 and is headquartered in Mumbai, India.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 21.23B | 30.23B | 18.76B | 11.33B | 10.38B | 10.60B | 8.52B | 7.78B | 6.52B | 6.07B | 5.67B | 4.96B |
Cost of Revenue | 12.36B | 17.84B | 11.88B | 7.26B | 6.10B | 6.55B | 5.58B | 4.98B | 3.88B | 3.83B | 3.50B | 3.50B |
Gross Profit | 8.87B | 12.39B | 6.88B | 4.07B | 4.28B | 4.05B | 2.94B | 2.80B | 2.65B | 2.24B | 2.17B | 1.47B |
Gross Profit Ratio | 41.77% | 40.98% | 36.66% | 35.90% | 41.26% | 38.19% | 34.48% | 36.01% | 40.56% | 36.94% | 38.30% | 29.52% |
Research & Development | 16.74M | 13.62M | 9.27M | 8.77M | 9.21M | 9.15M | 10.49M | 10.76M | 12.47M | 44.76M | 37.95M | 36.58M |
General & Administrative | 1.20B | 198.32M | 133.30M | 110.60M | 104.63M | 103.50M | 89.13M | 62.69M | 73.05M | 41.20M | 52.72M | 31.10M |
Selling & Marketing | 46.64M | 244.66M | 105.90M | 75.72M | 72.87M | 83.93M | 10.80M | 5.67M | 4.01M | 8.91M | 79.93M | 69.87M |
SG&A | 1.25B | 442.98M | 239.20M | 186.32M | 177.50M | 187.43M | 99.92M | 68.36M | 77.06M | 50.11M | 132.65M | 100.97M |
Other Expenses | 0.00 | 641.52M | 522.00K | 3.35M | 971.00K | 29.73M | 8.82M | 7.90M | 12.76M | 9.20M | 4.08M | 10.00K |
Operating Expenses | 1.26B | 4.56B | 3.61B | 2.54B | 2.22B | 1.88B | 1.55B | 1.58B | 1.49B | 1.36B | 1.19B | 1.07B |
Cost & Expenses | 13.63B | 22.40B | 15.50B | 9.80B | 8.32B | 8.43B | 7.13B | 6.56B | 5.36B | 5.18B | 4.69B | 4.57B |
Interest Income | 481.32M | 112.47M | 60.79M | 68.27M | 79.70M | 16.75M | 4.60M | 10.25M | 11.99M | 2.23M | 1.36M | 4.60M |
Interest Expense | 24.33M | 45.74M | 36.96M | 52.24M | 38.07M | 6.29M | 20.93M | 38.20M | 60.96M | 70.84M | 72.29M | 79.16M |
Depreciation & Amortization | 562.79M | 478.93M | 399.03M | 467.69M | 346.55M | 174.54M | 200.44M | 237.13M | 295.64M | 225.77M | 106.10M | 113.55M |
EBITDA | 6.05B | 8.95B | 3.98B | 2.16B | 2.61B | 2.53B | 1.74B | 1.49B | 1.53B | 1.11B | 1.08B | 523.22M |
EBITDA Ratio | 28.52% | 29.55% | 21.03% | 18.92% | 25.04% | 23.46% | 20.20% | 19.16% | 23.48% | 18.51% | 19.81% | 10.12% |
Operating Income | 7.60B | 7.83B | 3.26B | 1.53B | 2.06B | 2.17B | 1.39B | 1.22B | 1.16B | 883.51M | 979.86M | 399.48M |
Operating Income Ratio | 35.82% | 25.91% | 17.37% | 13.51% | 19.87% | 20.47% | 16.29% | 15.67% | 17.79% | 14.56% | 17.28% | 8.05% |
Total Other Income/Expenses | -2.16B | -2.72B | -2.33B | -1.54B | 149.64M | 137.61M | 124.30M | -6.52M | 15.47M | -56.73M | -34.16M | -89.91M |
Income Before Tax | 5.44B | 8.41B | 3.52B | 1.62B | 2.21B | 2.31B | 1.51B | 1.22B | 1.18B | 826.78M | 945.70M | 309.57M |
Income Before Tax Ratio | 25.63% | 27.82% | 18.74% | 14.31% | 21.31% | 21.76% | 17.75% | 15.62% | 18.02% | 13.63% | 16.67% | 6.24% |
Income Tax Expense | 1.32B | 2.23B | 918.19M | 418.08M | 513.22M | 945.22M | 558.60M | 432.10M | 411.05M | 294.93M | 328.24M | 100.60M |
Net Income | 4.12B | 6.18B | 2.60B | 1.20B | 1.65B | 1.36B | 953.27M | 783.62M | 764.81M | 531.85M | 617.46M | 208.97M |
Net Income Ratio | 19.40% | 20.45% | 13.84% | 10.62% | 15.87% | 12.85% | 11.19% | 10.07% | 11.72% | 8.77% | 10.89% | 4.21% |
EPS | 134.34 | 201.60 | 84.67 | 39.24 | 53.74 | 44.43 | 31.09 | 25.40 | 24.95 | 18.35 | 21.31 | 7.21 |
EPS Diluted | 134.34 | 201.60 | 84.67 | 39.24 | 53.74 | 44.43 | 31.09 | 25.40 | 24.95 | 18.35 | 21.31 | 7.21 |
Weighted Avg Shares Out | 30.66M | 30.66M | 30.66M | 30.66M | 30.66M | 30.66M | 30.66M | 30.66M | 30.66M | 28.98M | 28.98M | 28.98M |
Weighted Avg Shares Out (Dil) | 30.66M | 30.66M | 30.66M | 30.66M | 30.66M | 30.66M | 30.66M | 30.66M | 30.66M | 28.98M | 28.98M | 28.98M |
Source: https://incomestatements.info
Category: Stock Reports